Aphria and MassRoots Partner in One of First International ... · MassRoots common stock, along...

Post on 10-Jun-2020

1 views 0 download

Transcript of Aphria and MassRoots Partner in One of First International ... · MassRoots common stock, along...

1

AphriaandMassRootsPartnerinOneofFirstInternationalCollaborationsbetweenCannabis

Companies

Leamington,Ontario–October18,2016–AphriaInc.(“Aphria”orthe“Company”)(TSX-V:APHorUSOTCQB:APHQF)oneoftheleadingCanadianlicensedproducersofmedicalcannabis,andMassRoots,Inc.(OTCQB:MSRT),oneofthelargesttechnology platforms for the cannabis industry, are pleased to announce they have entered into one of the firstinternationalpartnershipsbetweencannabiscompanies. Under the termsof theagreement,MassRootswillhelpbuildawarenessoftheAphriabrandamongstitsCanadianuserbase.AphriawillcompensateMassRootsacashfee(inU.S.dollars)perpatientitrefers.

“WearethrilledtopartnerwithAphriatohelpexpandtheirpatientbasewhileopeninganewrevenuestreamforourbusiness,”statedMassRootsCEOIsaacDietrich.“Asatechnologyplatform,MassRootsisavailableineverystateandcountrythatregulatestheproductionofcannabisandwecouldnotbemoreexcitedtohaveapartnerofAphria’scaliberintheCanadianmarket.”

“ThispartnershipwithMassRootsoffersafresh,innovativewaytoexpandAphria’spatientbasewhilehelpingtogrowourdigitalpresence,”statedAphriaCEOVicNeufeld.“MassRootshasthepotentialtobetheleadingtechnologyplatforminthecannabissectorandwelookforwardtoleveragingtheirdistributionchannelsanddatatooptimizeouroperations.”

OnMonday,October17,2016,Aphria, Inc. invested$250,000USD inMassRootsbypurchasing500,000sharesofMassRootscommonstock,alongwithreceivingwarrantstopurchaseanadditional500,000sharesat$0.90pershare,validuntilOctober17,2019underMassRoots’RegisteredOfferingdeclaredeffectivebytheUnitedStatesSecuritiesandExchangeCommissiononAugust11,2016.ThepartnershipwithMassRootsandtherelatedequityinvestmentremainsubjecttoregulatoryapprovals,includingtheapprovaloftheTSXVentureExchange.

AboutMassRoots

MassRootsisoneofthelargestandmostactivetechnologyplatformsforcannabisconsumers,businessesandactivistswithover900,000registeredusers.Itisproudtobeaffiliatedwiththeleadingorganizationsinthecannabisindustry,includingtheArcViewGroupandNationalCannabisIndustryAssociation.MassRootshasbeencoveredbyFoxBusiness,CNBC,Fortune,DenverPost,andTheFinancialTimes.Formoreinformation,pleasevisitMassRoots.com/Investors.

AboutAphriaAphriaInc.,oneofCanada'slowestcostproducers,produces,suppliesandsellsmedicalcannabis.LocatedinLeamington,Ontario,thegreenhousecapitalofCanada.Aphriaistrulypoweredbysunlight,allowingforthemostnaturalgrowingconditionsavailable.Wearecommittedtoprovidingpharma-grademedicalcannabis,superiorpatientcarewhilebalancingpatienteconomicsandreturnstoshareholders.Wearethefirstpubliclicencedproducertoreportpositivecashflowfromoperationsandthefirsttoreportpositiveearningsinconsecutivequarters.Formoreinformation,visitwww.Aphria.com

2

Forfurtherinformationpleasecontact:

VicNeufeld IsaacDietrichAphriaInc. MassRoots,Inc.President&CEO CEO1-844-427-4742 1-757-705-4238

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news releaseconstitutesforward-lookingstatementsunderapplicablesecurities laws.Anystatementsthatarecontained inthisnewsreleasethatarenotstatementsofhistoricalfactmaybedeemedtobeforward-lookingstatements.Forward-lookingstatementsareoftenidentifiedbytermssuchas“may”,“should”,“anticipate”,“expect”,“believe”,“intend”orthenegativeofthesetermsandsimilarexpressions.Forward-lookingstatementsinthisnewsreleaseinclude,butarenotlimitedto,thegrowthofMassRoots’business,thegrowthofAphria’sbusiness,potentialpartnerships,newfeatures, related business strategies, statements with respect to internal expectations, estimated margins,expectations for future growing capacity, the expected growth of production facilities in North America, anycommentaryrelatedtothelegalizationofmarijuanaandthetimingrelatedthereto,andexpectationswithrespecttofutureproductioncosts.Forward-lookingstatementsnecessarilyinvolveknownandunknownrisks,including,withoutlimitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss ofmarkets; future legislative and regulatory developments involvingmedicalmarijuana; inability to access sufficientcapitalfrominternalandexternalsources,and/orinabilitytoaccesssufficientcapitalonfavourableterms;themedicalmarijuana industry inCanadagenerally, income tax and regulatorymatters; the abilityofAphriaorMassRoots toimplementitsbusinessstrategies;competition;cropfailure;currencyandinterestratefluctuationsandotherrisks.Readersarecautioned that the foregoing list isnotexhaustive.Readersare furthercautionednot toplaceunduerelianceonforward-lookingstatementsastherecanbenoassurancethattheplans,intentionsorexpectationsuponwhichtheyareplacedwilloccur.Suchinformation,althoughconsideredreasonablebymanagementatthetimeofpreparation,may prove to be incorrect and actual resultsmay differmaterially from those anticipated. Forward-lookingstatementscontainedinthisnewsreleaseareexpresslyqualifiedbythiscautionarystatement.NeithertheTSXVentureExchange(the“Exchange”)noritsRegulationServicesProvider(asthattermisdefinedinthepoliciesoftheExchange)acceptsresponsibilityfortheadequacyoraccuracyofthisrelease.